{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:03:39Z","timestamp":1780297419269,"version":"3.54.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018638","name":"Abdul Hameed Shoman Foundation","doi-asserted-by":"publisher","award":["25080310"],"award-info":[{"award-number":["25080310"]}],"id":[{"id":"10.13039\/501100018638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009606","name":"Arabian Gulf University","doi-asserted-by":"publisher","award":["#G2\/AGU-01\/26"],"award-info":[{"award-number":["#G2\/AGU-01\/26"]}],"id":[{"id":"10.13039\/100009606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009697","name":"Hashemite University","doi-asserted-by":"publisher","award":["785\/48\/2022"],"award-info":[{"award-number":["785\/48\/2022"]}],"id":[{"id":"10.13039\/501100009697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009697","name":"Hashemite University","doi-asserted-by":"publisher","award":["738\/54\/2022"],"award-info":[{"award-number":["738\/54\/2022"]}],"id":[{"id":"10.13039\/501100009697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.trim.2026.102384","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T11:20:29Z","timestamp":1775388029000},"page":"102384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of immunosuppressive therapy on non-melanoma skin cancer after solid organ transplantation: A critical systematic review"],"prefix":"10.1016","volume":"96","author":[{"given":"Joseph A.","family":"Abulail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Abu Husein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Al-Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Jaradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatha","family":"Alhawamdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Elkhalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raneem","family":"Esaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofian","family":"Al Shboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.trim.2026.102384_bb0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM200003023420907","article-title":"Improving the success of organ transplantation","volume":"342","author":"Carpenter","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.trim.2026.102384_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040754","article-title":"Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients","volume":"7","author":"Muehleisen","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trre.2017.10.002","article-title":"Cancer evaluation in the assessment of solid organ transplant candidates: a systematic review of clinical practice guidelines","volume":"32","author":"Acuna","year":"2018","journal-title":"Transplant Rev Orlando Fla."},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40257-018-0355-8","article-title":"Skin cancer following solid organ transplantation: a review of risk factors and models of care","volume":"19","author":"Howard","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"issue":"6","key":"10.1016\/j.trim.2026.102384_bb0025","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.trim.2026.102384_bb0030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.TP.0000436907.56425.5c","article-title":"Predictors of cancer risk in the long-term solid-organ transplant recipient","volume":"97","author":"Sherston","year":"2014","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.trim.2026.102384_bb0035","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.mayocp.2018.04.025","article-title":"Immunosuppression, race, and donor-related risk factors affect de novo cancer incidence across solid organ transplant recipients","volume":"93","author":"Bhat","year":"2018","journal-title":"Mayo Clin. Proc."},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0040","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/TP.0000000000001385","article-title":"Clinical and economic consequences of early cancer after kidney transplantation in contemporary practice","volume":"101","author":"Dharnidharka","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000001447","article-title":"Cancer and mTOR inhibitors in transplant recipients","volume":"101","author":"de Fijter","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2026.102384_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103754","article-title":"Current knowledge of immunosuppression as a risk factor for skin cancer development","volume":"177","author":"Rollan","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.trim.2026.102384_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2014.02.039","article-title":"Skin cancer in organ transplant recipients: more than the immune system","volume":"71","author":"Wheless","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0625.2011.01413.x","article-title":"Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair","volume":"21","author":"Kuschal","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"12","key":"10.1016\/j.trim.2026.102384_bb0065","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and Meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0070","article-title":"A review of the potential utility of mycophenolate mofetil as a cancer therapeutic","volume":"2014","author":"Majd","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.trim.2026.102384_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.trim.2026.102384_bb0080","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bcp.14979","article-title":"Mycophenolic acid and cancer risk in solid organ transplant recipients: systematic review and meta-analysis","volume":"88","author":"Hirunsatitpron","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.trim.2026.102384_bb0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.tp.0000234905.56926.7f","article-title":"Induction immunosuppression","volume":"82","author":"Kirk","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2026.102384_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/tri.13079","article-title":"Center practice drives variation in choice of U.S. kidney transplant induction therapy: a retrospective analysis of contemporary practice","volume":"31","author":"Dharnidharka","year":"2018","journal-title":"Transpl. Int."},{"issue":"12","key":"10.1016\/j.trim.2026.102384_bb0095","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1111\/ajt.15513","article-title":"The use of induction therapy in liver transplantation is highly variable and is associated with post-transplant outcomes","volume":"19","author":"Bittermann","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2026.102384_bb0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10741-018-9691-2","article-title":"Induction immunosuppressive therapy in cardiac transplantation: a systematic review and meta-analysis","volume":"23","author":"Briasoulis","year":"2018","journal-title":"Heart Fail. Rev."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajt.2024.11.011","article-title":"The role of induction therapy in lung transplantation","volume":"25","author":"Landino","year":"2025","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"key":"10.1016\/j.trim.2026.102384_bb0110","first-page":"1","article-title":"Optimizing use of basiliximab in liver transplantation","volume":"2","author":"Ramirez","year":"2010","journal-title":"Transpl Res Risk Manag."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.anclin.2017.04.001","article-title":"Overview of immunosuppressive therapy in solid organ transplantation","volume":"35","author":"Holt","year":"2017","journal-title":"Anesthesiol. Clin."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0120","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1038\/s41598-023-32972-z","article-title":"T-cell specific antibody induction versus corticosteroid induction immunosuppression for liver transplant recipients: a meta-analysis","volume":"13","author":"Jung","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5500\/wjt.v11.i4.99","article-title":"Does steroid-free immunosuppression improve the outcome in kidney transplant recipients compared to conventional protocols?","volume":"11","author":"Aref","year":"2021","journal-title":"World J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2026.102384_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.healun.2008.01.022","article-title":"Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation","volume":"27","author":"Hartwig","year":"2008","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0135","first-page":"459","article-title":"Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants","volume":"137","author":"Otley","year":"2001","journal-title":"Arch. Dermatol."},{"issue":"2 Pt 1","key":"10.1016\/j.trim.2026.102384_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(89)70157-2","article-title":"Cutaneous manifestations of immunosuppression in organ transplant recipients","volume":"21","author":"Abel","year":"1989","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.trim.2026.102384_bb0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00007890-198708000-00022","article-title":"Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice","volume":"44","author":"Servilla","year":"1987","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.trim.2026.102384_bb0150","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1111\/ajt.15495","article-title":"Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer","volume":"19","author":"Engels","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2026.102384_bb0155","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.transproceed.2010.08.003","article-title":"Incidence and risk factors for nonmelanoma skin cancer after heart transplantation","volume":"42","author":"Molina","year":"2010","journal-title":"Transplant. Proc."},{"issue":"10","key":"10.1016\/j.trim.2026.102384_bb0160","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ad.2014.06.001","article-title":"The role of new immunosuppressive drugs in nonmelanoma skin cancer in renal transplant recipients","volume":"105","author":"Bernat-Garc\u00eda","year":"2014","journal-title":"Actas Dermosifiliogr."},{"issue":"12","key":"10.1016\/j.trim.2026.102384_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14121","article-title":"Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: a prospective cohort study","volume":"34","author":"Wang","year":"2020","journal-title":"Clin. Transpl."},{"issue":"2","key":"10.1016\/j.trim.2026.102384_bb0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"22","key":"10.1016\/j.trim.2026.102384_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.12659\/AOT.901556","article-title":"Conversion from calcineurin inhibitor-based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation","volume":"7","author":"Aguiar","year":"2017","journal-title":"Ann. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2026.102384_bb0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.healun.2018.03.012","article-title":"Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation","volume":"37","author":"Vos","year":"2018","journal-title":"J. Heart Lung Transplant."},{"issue":"1\u20132","key":"10.1016\/j.trim.2026.102384_bb0185","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0041-1345(98)01928-9","article-title":"Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?","volume":"31","author":"Jensen","year":"1999","journal-title":"Transplant. Proc."},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0190","article-title":"Cyclosporin versus tacrolimus for liver transplanted patients","volume":"2006","author":"Haddad","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.trim.2026.102384_bb0195","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients","author":"Penninga","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.trim.2026.102384_bb0200","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.3390\/curroncol30060430","article-title":"Systematic review of calcineurin inhibitors and incidence of skin malignancies after kidney transplantation in adult patients: a study of 309,551 cases","volume":"30","author":"Kulbat","year":"2023","journal-title":"Curr. Oncol."},{"issue":"11","key":"10.1016\/j.trim.2026.102384_bb0205","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/tri.12850","article-title":"Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study","volume":"29","author":"Dharnidharka","year":"2016","journal-title":"Transpl. Int."},{"issue":"9","key":"10.1016\/j.trim.2026.102384_bb0210","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.12795","article-title":"A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients","volume":"14","author":"Lim","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2026.102384_bb0215","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40620-014-0098-4","article-title":"Skin cancer in kidney transplant recipients","volume":"27","author":"Ponticelli","year":"2014","journal-title":"J. Nephrol."},{"issue":"7737","key":"10.1016\/j.trim.2026.102384_bb0225","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0140-6736(71)90602-7","article-title":"Skin cancer and immunosuppression","volume":"2","author":"Walder","year":"1971","journal-title":"Lancet Lond Engl."},{"key":"10.1016\/j.trim.2026.102384_bb0230","first-page":"14","article-title":"Incidence of nonmelanoma skin cancer in renal transplant recipients: a systematic review and meta-analysis","volume":"23","author":"Matinfar","year":"2018","journal-title":"J Res Med Sci Off J Isfahan Univ Med Sci."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0235","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.tp.0000269707.06060.dc","article-title":"Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients","volume":"84","author":"Ramsay","year":"2007","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0240","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.TP.0000108491.62935.DF","article-title":"Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate","volume":"77","author":"Bordea","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2026.102384_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1017498","article-title":"Skin cancer outcomes and risk factors in renal transplant recipients: analysis of organ procurement and transplantation network data from 2000 to 2021","volume":"12","author":"Hao","year":"2022","journal-title":"Front. Oncol."},{"issue":"2 Pt 1","key":"10.1016\/j.trim.2026.102384_bb0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"40","author":"Jensen","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0255","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2133.1993.tb11841.x","article-title":"Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients","volume":"129","author":"Bavinck","year":"1993","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/ajkd.2000.8290","article-title":"Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients","volume":"36","author":"Ramsay","year":"2000","journal-title":"Am J Kidney Dis Off J Natl Kidney Found."},{"key":"10.1016\/j.trim.2026.102384_bb0265","doi-asserted-by":"crossref","DOI":"10.18332\/tid\/185299","article-title":"Tobacco smoking is associated with cutaneous squamous cell carcinoma but not with basal cell carcinoma or melanoma in adult subjects at risk of skin cancer: a cross-sectional study","volume":"22","author":"Uotila","year":"2024","journal-title":"Tob. Induc. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2026.102384_bb0270","first-page":"60","article-title":"Induction immunosuppressive therapy in kidney transplantation","volume":"12","author":"Bakr","year":"2014","journal-title":"Exp Clin Transplant Off J Middle East Soc Organ Transplant."},{"issue":"2S1","key":"10.1016\/j.trim.2026.102384_bb0275","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ajt.2025.01.020","article-title":"OPTN\/SRTR 2023 annual data report: kidney","volume":"25","author":"Lentine","year":"2025","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0280","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","volume":"2010","author":"Webster","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.trim.2026.102384_bb0285","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients","volume":"67","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0290","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.00640805","article-title":"Role of maintenance immunosuppressive regimen in kidney transplant outcome","volume":"1","author":"Goldfarb-Rumyantzev","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0295","first-page":"177","article-title":"Immunosuppression in kidney transplantation","volume":"86","author":"Muntean","year":"2013","journal-title":"Clujul Med."},{"issue":"2","key":"10.1016\/j.trim.2026.102384_bb0300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5114\/ada.2023.127637","article-title":"Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review","volume":"40","author":"Olszewska","year":"2023","journal-title":"Adv. Dermatol. Allergol."},{"issue":"8","key":"10.1016\/j.trim.2026.102384_bb0305","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.transproceed.2007.08.016","article-title":"Long-term maintenance of calcineurin inhibitor monotherapy reduces the risk for squamous cell carcinomas after kidney transplantation compared with bi- or tritherapy","volume":"39","author":"Abou Ayache","year":"2007","journal-title":"Transplant. Proc."},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0310","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2340\/00015555-1316","article-title":"Skin cancer and other cutaneous disorders in liver transplant recipients","volume":"92","author":"Belloni-Fortina","year":"2012","journal-title":"Acta Derm. Venereol."},{"issue":"10","key":"10.1016\/j.trim.2026.102384_bb0315","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4254\/wjh.v7.i10.1355","article-title":"Review on immunosuppression in liver transplantation","volume":"7","author":"Moini","year":"2015","journal-title":"World J. Hepatol."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2004.12.011","article-title":"Incidence and risk factors for cancer after liver transplantation","volume":"56","author":"Vallejo","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.trim.2026.102384_bb0325","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.transproceed.2012.05.005","article-title":"Subsequent nonmelanoma skin cancer after liver transplantation","volume":"44","author":"Herrero","year":"2012","journal-title":"Transplant. Proc."},{"issue":"8","key":"10.1016\/j.trim.2026.102384_bb0330","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit","volume":"10","author":"Collett","year":"2010","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"key":"10.1016\/j.trim.2026.102384_bb0335","doi-asserted-by":"crossref","unstructured":"Ramos HC, Reyes J, Abu-Elmagd K, Zeevi A, Reinsmoen N, Tzakis A, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995 Jan 27;59(2):212\u20137. doi:https:\/\/doi.org\/10.1097\/00007890-199501270-00010 PubMed PMID: 7839442; PubMed Central PMCID: PMC3005337.","DOI":"10.1097\/00007890-199501270-00010"},{"issue":"1\u20132","key":"10.1016\/j.trim.2026.102384_bb0340","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0041-1345(96)00535-0","article-title":"Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up","volume":"29","author":"Mazariegos","year":"1997","journal-title":"Transplant. Proc."},{"issue":"2S1","key":"10.1016\/j.trim.2026.102384_bb0345","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.ajt.2025.01.022","article-title":"OPTN\/SRTR 2023 annual data report: liver","volume":"25","author":"Kwong","year":"2025","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0350","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/lv.2000.6352","article-title":"Skin cancer in liver transplant recipients","volume":"6","author":"Otley","year":"2000","journal-title":"Liver Transpl."},{"issue":"7","key":"10.1016\/j.trim.2026.102384_bb0355","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jid.2016.02.804","article-title":"Prevalence of skin cancer and related skin tumors in high-risk kidney and liver transplant recipients in Queensland, Australia","volume":"136","author":"Iannacone","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.trim.2026.102384_bb0360","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamadermatol.2022.3878","article-title":"Differences in skin cancer rates by transplanted organ type and patient age after organ transplant in white patients","volume":"158","author":"Wheless","year":"2022","journal-title":"JAMA Dermatol."},{"issue":"10","key":"10.1016\/j.trim.2026.102384_bb0365","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1053\/jlts.2002.35551","article-title":"Risk factors associated with the development of skin cancer after liver transplantation","volume":"8","author":"Mithoefer","year":"2002","journal-title":"Liver Transpl."},{"issue":"7","key":"10.1016\/j.trim.2026.102384_bb0370","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/lt.23381","article-title":"Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up","volume":"18","author":"Mangus","year":"2012","journal-title":"Liver Transpl."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0375","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2014.09.010","article-title":"Incidence and risk factors for skin cancer following lung transplantation","volume":"72","author":"Rashtak","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.trim.2026.102384_bb0380","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2020.02.126","article-title":"Malignancy after lung transplantation","volume":"8","author":"Shtraichman","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.trim.2026.102384_bb0385","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7089482","article-title":"Risk factors for developing nonmelanoma skin cancer after lung transplantation","volume":"2019","author":"Gr\u00e4ger","year":"2019","journal-title":"J. Skin Cancer"},{"issue":"10","key":"10.1016\/j.trim.2026.102384_bb0390","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Yusen","year":"2016","journal-title":"J. Heart Lung Transplant."},{"issue":"Suppl. 2","key":"10.1016\/j.trim.2026.102384_bb0395","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12055-021-01225-x","article-title":"Induction and maintenance immunosuppression in lung transplantation","volume":"38","author":"Small","year":"2022","journal-title":"Indian J. Thorac. Cardiovasc. Surg."},{"issue":"2 Suppl 1","key":"10.1016\/j.trim.2026.102384_bb0400","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1016\/j.ajt.2025.01.025","article-title":"OPTN\/SRTR 2023 annual data report: lung","volume":"25","author":"Valapour","year":"2025","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"10","key":"10.1016\/j.trim.2026.102384_bb0405","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1097\/TP.0000000000000687","article-title":"Evaluation of alemtuzumab versus basiliximab induction: a retrospective cohort study in lung transplant recipients","volume":"99","author":"Whited","year":"2015","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.trim.2026.102384_bb0410","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2004.09.002","article-title":"A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation","volume":"24","author":"Hachem","year":"2005","journal-title":"J. Heart Lung Transplant."},{"issue":"8","key":"10.1016\/j.trim.2026.102384_bb0415","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/ajt.12824","article-title":"Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study","volume":"14","author":"Jaksch","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2026.102384_bb0420","article-title":"Antibody induction therapy for lung transplant recipients","volume":"2013","author":"Penninga","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0425","doi-asserted-by":"crossref","DOI":"10.21542\/gcsp.2018.5","article-title":"Individualizing immunosuppression in lung transplantation","volume":"2018","author":"McDermott","year":"2018","journal-title":"Global Cardiology Science and Practice"},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0430","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1183\/09031936.03.00039203","article-title":"Immunosuppressive therapy after human lung transplantation","volume":"23","author":"Knoop","year":"2004","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.trim.2026.102384_bb0435","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13718","article-title":"Factors associated with skin cancer in lung transplant recipients: a single-center experience","volume":"33","author":"Elnahas","year":"2019","journal-title":"Clin. Transpl."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0440","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ijd.14549","article-title":"Mammalian target of rapamycin (mTOR) inhibitors and skin cancer risk in nonrenal solid organ transplant recipients: systematic review and meta-analysis","volume":"59","author":"Phan","year":"2020","journal-title":"Int. J. Dermatol."},{"issue":"12","key":"10.1016\/j.trim.2026.102384_bb0445","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.healun.2025.04.014","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: 2025 annual report of heart and lung transplantation","volume":"44","author":"Singh","year":"2025","journal-title":"J Heart Lung Transplant Off Publ Int Soc Heart Transplant"},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0450","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.abd.2024.05.004","article-title":"Skin cancer after heart transplantation: a systematic review","volume":"100","author":"Aguzzoli NHG","year":"2025","journal-title":"An. Bras. Dermatol."},{"issue":"6","key":"10.1016\/j.trim.2026.102384_bb0455","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/0284186X.2019.1580385","article-title":"Cancer incidence and mortality after heart transplantation - a population-based national cohort study","volume":"58","author":"J\u00e4\u00e4maa-Holmberg","year":"2019","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0460","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00403-024-03759-7","article-title":"Incidence and risk factors for skin cancer after heart transplantation: a systematic review and meta-analysis","volume":"317","author":"Yang","year":"2025","journal-title":"Arch. Dermatol. Res."},{"issue":"11","key":"10.1016\/j.trim.2026.102384_bb0465","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1432-2277.2005.00203.x","article-title":"Incidence and prognosis of cancer following heart transplantation using RATG induction therapy","volume":"18","author":"El-Hamamsy","year":"2005","journal-title":"Transpl. Int."},{"issue":"12","key":"10.1016\/j.trim.2026.102384_bb0470","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archdermatol.2009.276","article-title":"Incidence of and risk factors for skin cancer after heart transplant","volume":"145","author":"Brewer","year":"2009","journal-title":"Arch. Dermatol."},{"issue":"9","key":"10.1016\/j.trim.2026.102384_bb0475","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-4632.2008.03711.x","article-title":"Non-melanoma skin cancer and its risk factors in an austrian population of heart transplant recipients receiving induction therapy","volume":"47","author":"Geusau","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.trim.2026.102384_bb0480","doi-asserted-by":"crossref","first-page":"300","DOI":"10.12659\/AOT.890199","article-title":"Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine A and tacrolimus","volume":"19","author":"Fuchs","year":"2014","journal-title":"Ann. Transplant."},{"issue":"C","key":"10.1016\/j.trim.2026.102384_bb0485","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijscr.2021.01.031","article-title":"Recurrent squamous cell carcinoma in a post cardiac transplant patient","volume":"79","author":"Ruwanpathirana","year":"2021","journal-title":"Int. J. Surg. Case Rep."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0490","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10741-020-09967-3","article-title":"Maintenance immunosuppression in heart transplantation: insights from network meta-analysis of various immunosuppression regimens","volume":"27","author":"Ueyama","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"2","key":"10.1016\/j.trim.2026.102384_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13020558","article-title":"Heart transplantation","volume":"13","author":"Chrysakis","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trim.2026.102384_bb0500","first-page":"93","article-title":"Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy","volume":"9","author":"Rivinius","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"issue":"7","key":"10.1016\/j.trim.2026.102384_bb0505","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1600-6143.2011.03598.x","article-title":"Increased incidence and mortality associated with skin cancers after cardiac transplant","volume":"11","author":"Alam","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.trim.2026.102384_bb0510","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00403-023-02646-x","article-title":"A review of heart transplant immunosuppressants and nonmelanoma skin cancer","volume":"315","author":"Eckembrecher","year":"2023","journal-title":"Arch. Dermatol. Res."},{"issue":"2S1","key":"10.1016\/j.trim.2026.102384_bb0515","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.ajt.2025.01.021","article-title":"OPTN\/SRTR 2023 Annual Data Report: Pancreas","volume":"25","author":"Kandaswamy","year":"2025","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"2S1","key":"10.1016\/j.trim.2026.102384_bb0520","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1016\/j.ajt.2025.01.023","article-title":"OPTN\/SRTR 2023 Annual Data Report: Intestine","volume":"25","author":"Horslen","year":"2025","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0525","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/clinem\/dgac644","article-title":"Pancreas transplantation: current challenges, considerations, and controversies","volume":"108","author":"Fridell","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0530","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015610","article-title":"Pancreas transplantation: solid organ and islet","volume":"4","author":"Mittal","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0535","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2011.11.939","article-title":"Skin cancer after pancreas transplantation","volume":"67","author":"Spanogle","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.trim.2026.102384_bb0540","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MOT.0000000000000958","article-title":"Update on immunosuppressive strategies in intestinal transplantation","volume":"27","author":"Merola","year":"2022","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"7S","key":"10.1016\/j.trim.2026.102384_bb0545","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.tp.0000945528.06591.a0","article-title":"18: patient variables predictive of post-intestinal transplantation malignancy","volume":"107","author":"Smullin","year":"2023","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.trim.2026.102384_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263210","article-title":"Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: using the CLASS method for determining specific causes of death","volume":"17","author":"S\u00f8borg","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.trim.2026.102384_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2024.100882","article-title":"Cutaneous squamous cell carcinoma in solid organ transplant recipients: current therapeutic and screening strategies","volume":"38","author":"Struckmeier","year":"2024","journal-title":"Transplant. Rev."},{"issue":"5","key":"10.1016\/j.trim.2026.102384_bb0560","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1053\/j.ajkd.2012.12.007","article-title":"Can the risk of skin cancer after transplantation be reduced by mTOR inhibitors?","volume":"61","author":"Carroll","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0565","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2026.102384_bb0570","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/TP.0b013e3181a5ce2e","article-title":"Predicting risk of nonmelanoma skin cancer and premalignant skin lesions in renal transplant recipients","volume":"87","author":"Urwin","year":"2009","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.trim.2026.102384_bb0575","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jdv.15458","article-title":"The effects of a multidisciplinary high-throughput skin clinic on healthcare costs of organ transplant recipients","volume":"33","author":"Gordon","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.trim.2026.102384_bb0580","first-page":"18","article-title":"Incidence and risk factors for skin cancer in liver transplant recipients: a systematic review","volume":"32","author":"McGinnis","year":"2026","journal-title":"Liver Transpl. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transpl. Soc."},{"issue":"3","key":"10.1016\/j.trim.2026.102384_bb0585","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:49:09Z","timestamp":1780296549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":117,"alternative-id":["S0966327426000420"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102384","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of immunosuppressive therapy on non-melanoma skin cancer after solid organ transplantation: A critical systematic review","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102384"}}